eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
3/2021
vol. 72
 
Share:
Send email
Share:
abstract:
Original paper

Immunohistochemical evaluation of potential molecular targets of desmoid-type fibromatosis

Andrea Janegova
1
,
Zuzana Hlavata
2
,
Luboslav Mihok
3
,
Lucia Copakova
3
,
Pavel Babal
3
,
Pavol Janega
1

  1. Institute of Pathological Anatomy, Faculty of Medicine, Comenius University, Bratislava, Slovakia
  2. Department of Clinical Oncology, National Cancer Institute, Bratislava, Slovakia
  3. Department of Clinical Genetics, National Cancer Institute, Bratislava, Slovakia
Pol J Pathol 2021; 72 (3): 252-260
DOI: https://doi.org/10.5114/pjp.2021.111776
Online publish date: 2022/01/19
View full text Get citation
 
PlumX metrics:
Desmoid-type fibromatosis is locally aggressive tumor rare in general population, although commonly present in patients with familial adenomatous polyposis, significantly contributing to the morbidity and mortality of patients. To optimize and individualize the management of patients it is necessary to better understand the biology of these tumors. Immunohistochemical analysis of β-catenin, VEGF, hormone receptors ERβ, ERα and PR, COX-2, APC protein, EGFR, c-kit (CD117), bcl-2 and HER2 expression, potential therapeutic targets, was carried out on 15 archival

biopsy samples together with APC gene mutational screening. β-catenin expression was found in all samples, with over 73% showing high range positivity, however with no prognostic significance. Non-specific cytoplasmic localization of β-catenin was observed FAP-associated cases lacking CTNNB1 mutations. Hormone receptor status demonstrated expression of ERβ in 93% of lesions, without detectable ERα or PR. Distinct COX-2 expression of variable intensity was present in all but one desmoid-type fibromatosis case. All lesions demonstrated intense VEGF positivity. Immunoreactivity for the APC protein was found only in 4 cases associated with FAP. No EGFR, HER2, bcl-2 or c-kit expression was detected in any sample. Expression of β-catenin, VEGF, ERβ, COX-2 in high number of cases suggests a potential as future therapeutic targets in desmoid-type fibromatosis.
keywords:

desmoid-type fibromatosis, APC, familial adenomatous polyposis, targeted therapy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.